[HTML][HTML] COVID-19 therapeutic potential of natural products

Z Low, R Lani, V Tiong, C Poh, S AbuBakar… - International journal of …, 2023 - mdpi.com
Despite the fact that coronavirus disease 2019 (COVID-19) treatment and management are
now considerably regulated, severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

[HTML][HTML] Saline nasal irrigation and gargling in COVID-19: a multidisciplinary review of effects on viral load, mucosal dynamics, and patient outcomes

S Huijghebaert, S Parviz, D Rabago, A Baxter… - Frontiers in Public …, 2023 - frontiersin.org
With unrelenting SARS-CoV-2 variants, additional COVID-19 mitigation strategies are
needed. Oral and nasal saline irrigation (SI) is a traditional approach for respiratory …

[HTML][HTML] What we learned in the past year in managing our COVID-19 patients in intensive care units?

J Nitesh, R Kashyap, SR Surani - World journal of critical care …, 2021 - ncbi.nlm.nih.gov
Coronavirus disease 2019 is a pandemic, was first recognized at Wuhan province, China in
December 2019. The disease spread quickly across the globe, spreading stealthily from …

[HTML][HTML] Aerosol delivery systems for treating obstructive airway diseases during the SARS-CoV-2 pandemic

F Lavorini, OS Usmani, R Dhand - Internal and Emergency Medicine, 2021 - Springer
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes
CoronaVirus Disease 2019 (COVID-19), has resulted in a worldwide pandemic and …

The Impact of COVID‐19 on Hospitalised COPD Exacerbations in Malta

Y Farrugia, BP Spiteri Meilak, N Grech… - Pulmonary …, 2021 - Wiley Online Library
Introduction and Aims. The first COVID‐19 case in Malta was confirmed on the 7th of March
2020. This study is aimed at investigating a significant difference between the number of …

The impact of coronavirus disease 2019 on pediatric asthma in the United States

A Navalpakam, E Secord, M Pansare - Pediatric Clinics, 2021 - pediatric.theclinics.com
Coronaviruses are a common cause of upper respiratory infections in children. 1 A novel
human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

[HTML][HTML] One stone two birds: anti-inflammatory bronchodilators as a potential pharmacological strategy for COVID-19

Y Yu, B Fang, XD Yang, Y Zheng - Frontiers in Pharmacology, 2023 - frontiersin.org
The ongoing Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has imposed a huge threat to public …

[HTML][HTML] Long-and Short-Term Trends in Outpatient Attendance by Speciality in Japan: A Joinpoint Regression Analysis in the Context of the COVID-19 Pandemic

A Takeda, Y Ando, J Tomio - International Journal of Environmental …, 2023 - mdpi.com
The COVID-19 pandemic resulted in a decline in outpatient attendance. Therefore, this study
aimed to clarify long-and short-term clinic attendance trends by speciality in Japan between …

[HTML][HTML] Particle size analysis in aerosol-generating dental procedures using laser diffraction technique

K Onoyama, S Matsui, M Kikuchi, D Sato… - Frontiers in Oral …, 2022 - frontiersin.org
The global outbreak of coronavirus disease 2019 (COVID-19) has raised concerns about the
risk of airborne infection during dental treatment. Aerosol-generating dental procedures …

Delivery technology of inhaled therapy for asthma and COPD

MYT Chow, HW Pan, JKW Lam - Advances in Pharmacology, 2023 - Elsevier
Inhaled therapy is the cornerstone of the management of asthma and chronic obstructive
pulmonary disease (COPD). Drugs such as bronchodilators and corticosteroids are …